End of route navigation system
US-2025207934-A1 · Jun 26, 2025 · US
This page is not indexed by search engines while we improve data quality.
Wang Yulei patents
Wang Yulei is listed as an inventor on 20 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Wang Yulei |
| Total patents | 20 |
| First publication | Feb 16, 2017 |
| Latest publication | Jun 26, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
End of route navigation system
US-12281911-B2 · Apr 22, 2025 · US
Hepatocellular carcinoma molecular subtype classification and subtype specific treatments for hepatocellular carcinoma
US-2025054631-A1 · Feb 13, 2025 · US
Methods for treatment of cancer with an anti-tigit antagonist antibody
US-2024424092-A1 · Dec 26, 2024 · US
Vibrational microcavity modified chemical reactions
US-2024399334-A1 · Dec 5, 2024 · US
Tumor phenotype prediction using genomic analyses indicative of digital-pathology metrics
US-2024105283-A1 · Mar 28, 2024 · US
Diagnostic Methods and Methods of Treatment of Ovarian Cancer
US-2024084391-A1 · Mar 14, 2024 · US
CD8+ t cell based immunosuppressive tumor microenvironment detection method
US-11881286-B2 · Jan 23, 2024 · US
Diagnostic and therapeutic methods for cancer
US-2024011098-A1 · Jan 11, 2024 · US
Use of human epididymis protein 4 (he4) for assessing responsiveness of muc 16-positive cancer treatment
US-2023064677-A1 · Mar 2, 2023 · US
Recent patents
Latest publications not already listed above.
Diagnostic and therapeutic methods for cancer
US-11473151-B2 · Oct 18, 2022 · US
Use of human epididymis protein 4 (HE4) for assessing responsiveness of MUC 16-positive cancer treatment
US-11440969-B2 · Sep 13, 2022 · US
End of route navigation system
US-2022074759-A1 · Mar 10, 2022 · US
Methods for treatment of cancer with an anti-tigit antagonist antibody
US-2022016243-A1 · Jan 20, 2022 · US
Combination therapy for cancer comprising pd-1 axis binding antagonist and il6 antagonist
US-2021332143-A1 · Oct 28, 2021 · US
Tumor phenotype prediction using genomic analyses indicative of digital-pathology metrics
US-2021098082-A1 · Apr 1, 2021 · US
Diagnostic and therapeutic methods for cancer
US-2020263261-A1 · Aug 20, 2020 · US
Use of human epididymis protein 4 (he4) for assessing responsiveness of muc 16-positive cancer treatment
US-2019233538-A1 · Aug 1, 2019 · US
Compositions and methods for treating and diagnosing chemotherapy-resistant cancers
US-2017253933-A1 · Sep 7, 2017 · US
cDNA SYNTHESIS USING A REVERSIBLY INACTIVATED REVERSE TRANSCRIPTASE
US-2017044506-A1 · Feb 16, 2017 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Genentech Inc | 15 |
| Uber Technologies Inc | 3 |
| Hoffmann La Roche | 2 |
| Life Technologies Corp | 1 |
| Uchicago Argonne Llc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 10 |
| A61K2039/505 | 9 |
| C07K16/22 | 7 |
| G01N33/5758 | 6 |
| C12Q1/6886 | 6 |